ARCH Venture Partners VII, LLC — insider trades

Stock trades ARCH Venture Partners VII, LLC reported on SEC Form 4 at NMRA Neumora Therapeutics, Inc..

• Oct 27, 2025: bought 1,915,700 shares of NMRA Neumora Therapeutics, Inc. ($5.00M)